Trial intelligence / Profile preview

CONAN: Antibiotic Lock Solution Stability

NCT01592032Phase 4Unknown

Sponsor
Universidad de Navarra
Start
May 2012
Primary completion
Jan 2015
Modality
Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of vancomycin, teicoplanin, linezolid, daptomycin, tigecycline in Bacteremia, sponsored by Universidad de Navarra. Status: unknown.

02

Drugs

vancomycinteicoplaninlinezoliddaptomycintigecycline
03

Conditions

Bacteremia

Beyond the preview

Go deeper on NCT01592032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01592032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call